MedKoo Cat#: 562589 | Name: Wee1 Inhibitor II
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Wee1 Inhibitor II is a small-molecule inhibitor that selectively targets the Wee1 kinase, a key regulator of the G2/M checkpoint in the cell cycle. By inhibiting Wee1, it disrupts DNA damage repair and induces mitotic entry, making it a potential tool for studying cancer cell cycle regulation and sensitizing tumor cells to DNA-damaging agents. Its mechanism of action highlights its relevance in cancer research, particularly in exploring synthetic lethality approaches.

Chemical Structure

Wee1 Inhibitor II
Wee1 Inhibitor II
CAS#622855-50-9

Theoretical Analysis

MedKoo Cat#: 562589

Name: Wee1 Inhibitor II

CAS#: 622855-50-9

Chemical Formula: C24H19ClN2O3

Exact Mass: 418.1084

Molecular Weight: 418.87

Elemental Analysis: C, 68.82; H, 4.57; Cl, 8.46; N, 6.69; O, 11.46

Price and Availability

Size Price Availability Quantity
1mg USD 385.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Wee1 Inhibitor II; Wee1 Inhibitor-II; Wee1-Inhibitor-II; Wee1-Inhibitor II;
IUPAC/Chemical Name
6-Butyl-4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3-(2H,6H)-dione
InChi Key
HLSZACLAFZWCCS-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H19ClN2O3/c1-2-3-10-27-18-9-8-13(28)11-16(18)20-19(27)12-15(14-6-4-5-7-17(14)25)21-22(20)24(30)26-23(21)29/h4-9,11-12,28H,2-3,10H2,1H3,(H,26,29,30)
SMILES Code
O=C1NC(C2=C1C3=C(C=C2C4=CC=CC=C4Cl)N(CCCC)C5=C3C=C(O)C=C5)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 418.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Visconti R, Grieco D. Fighting tubulin-targeting anticancer drug toxicity and resistance. Endocr Relat Cancer. 2017 Sep;24(9):T107-T117. doi: 10.1530/ERC-17-0120. Review. PubMed PMID: 28808045. 2: Tamura K. Development of cell-cycle checkpoint therapy for solid tumors. Jpn J Clin Oncol. 2015 Dec;45(12):1097-102. doi: 10.1093/jjco/hyv131. Epub 2015 Oct 20. Review. PubMed PMID: 26486823. 3: Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci. 2001 Nov;58(12-13):1907-22. Review. PubMed PMID: 11766887. 4: Maller JL, Gross SD, Schwab MS, Finkielstein CV, Taieb FE, Qian YW. Cell cycle transitions in early Xenopus development. Novartis Found Symp. 2001;237:58-73; discussion 73-8. Review. PubMed PMID: 11444050.